Portolan Capital Management, LLC Care Dx, Inc. Transaction History
Portolan Capital Management, LLC
- $1.6 Billion
- Q3 2025
A detailed history of Portolan Capital Management, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Portolan Capital Management, LLC holds 933,532 shares of CDNA stock, worth $14.9 Million. This represents 0.85% of its overall portfolio holdings.
Number of Shares
933,532
Previous 629,977
48.19%
Holding current value
$14.9 Million
Previous $12.3 Million
10.27%
% of portfolio
0.85%
Previous 0.89%
Shares
4 transactions
Others Institutions Holding CDNA
# of Institutions
201Shares Held
54.9MCall Options Held
150KPut Options Held
57.6K-
Black Rock Inc. New York, NY5.29MShares$84.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.75MShares$59.8 Million0.0% of portfolio
-
Bamco Inc New York, NY3.16MShares$50.3 Million0.13% of portfolio
-
State Street Corp Boston, MA2.57MShares$40.9 Million0.0% of portfolio
-
Ophir Asset Management Pty LTD2.2MShares$35 Million4.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $852M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...